This in turn leads to excessive storage of underutilized glucose in the liver (glycogenesis), the potential for developing fatty liver (ie, nonalcoholic steatohepatitis), and conversion of excess carbohydrates to fatty acids and triglycerides, with subsequent storage in adipose tissue
Less frequent but more serious risks include pancreatitis, gallbladder issues, and in rare cases, thyroid tumors
We have told you exactly what is behind it, which is two separate evidence bases and a hypothesis nobody has tested
Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications
Semaglutide was originally developed for type 2 diabetes, where it produces HbA1c reductions of 1.52.0 percentage points